Skip to content

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo (BYZJ) Formula for constipation in Parkinson's disease

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo (BYZJ) Formula for constipation in Parkinson's disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030534
Enrollment
Unknown
Registered
2020-03-06
Start date
2020-03-23
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson' disease

Interventions

Sponsors

Beijing Rehabilitation Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as idiopathic PD according to the 2015 MDS criteria; 2. Diagnosed as constipation according to Rome III diagnostic criteria; 3. Aged 30 to 80 years; 4. Hoehn and Yahr classification 1-4; 5. Sign informed consent and be able to insist on completing the entire treatment process.

Exclusion criteria

Exclusion criteria: 1. Patients who do not take medication under the guidance of a professional doctor or cannot take medication regularly; 2. Patients with intestinal organic lesions such as intestinal polyps, intestinal tuberculosis, Crohn's disease, tumors and ulcers. etc; 3. Secondary constipation caused by uremia, muscular dystrophy, multiple sclerosis, hypothyroidism and other system diseases; 4. Patients with severe heart, brain, liver, kidney, blood system diseases, as well as mental disorders or dementia; 5. Higher serum creatinine, ALT or AST than twice the normal value; 6. According to the judgment of the researcher, patients who are unable to cooperate throughout the research due to drug abuse or poor adherence; 7. Participated in other studies in the past 2 weeks or is currently participating in other clinical trials; or has taken other traditional Chinese medicine preparations in the past 3 months; 8. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
constipation severity instrument;

Secondary

MeasureTime frame
PAC-QOL;BSFS;MDS-UPDRS;NMSS;PDSS;PFS-16;

Countries

China

Contacts

Public ContactZhaohui Jin

Beijing Rehabilitation Hospital, Capital Medical University

bestvin2004010201@163.com+86 15011367598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026